基本信息
浏览量:97
职业迁徙
个人简介
My primary research and teaching effort is directed toward the prevention of infectious diseases with the safest vaccines possible. I have conducted or participated in epidemiological studies of vaccine-preventable diseases and phase I, II, and III vaccine trials of hepatitis B, hepatitis A, inactivated polio virus, pertussis, Haemophilus influenzae type B, tetanus, Lyme disease, rotavirus, Argentina Hemorrhagic Fever, and influenzae vaccine viruses. The control of measles has been a particular focus of interest and I support the ongoing measles and poliomyelitis eradication efforts. My interest in vaccine safety stems from experience with vaccine-associated paralytic poliomyelitis, increased mortality after high-titer measles vaccines, and differences in response to acellular and wholecell pertussis vaccines. On-going studies include: persistent poliovirus excretion in immunodeficient children, evaluation of Lyme disease vaccine in children, evaluation of alternative injection devices, and the safety of preservatives and adjuvants in vaccines.
研究兴趣
论文共 450 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Neal Halsey, Stephen Evans,Mathuram Santosham,Adam Hacker,Kathryn M. Edwards,Rebecca E. Chandler,Matthew Z. Dudley,Cornelia L. Dekker,Seif Al-Abri,Narendra Arora,Jim Buttery, Alex Dodoo, Juhani Eskola,Ulrich Heininger,Youngmee Jee,Najwa Khuri,Stephen Obaro,Walt Orenstein,Punnee Pitisuttithum,Marco Safadi,Cynthia G. Whitney,Steve Black
Vaccineno. 22 (2023): 3399-3402
Vaccineno. 34 (2022): 4955-4963
The Lancet. Infectious diseasesno. 5 (2020): e80-e89
Vaccineno. 43 (2019): 6478-6485
The Clinician’s Vaccine Safety Resource Guidepp.173-177, (2018)
The Clinician’s Vaccine Safety Resource Guidepp.117-122, (2018)
The Clinician’s Vaccine Safety Resource Guidepp.237-239, (2018)
加载更多
作者统计
#Papers: 443
#Citation: 18156
H-Index: 72
G-Index: 120
Sociability: 7
Diversity: 0
Activity: 0
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn